walk2Wellness: Long-term Effects of Walkasins® Wearable Sensory Prosthesis
Status: | Recruiting |
---|---|
Conditions: | Neurology |
Therapuetic Areas: | Neurology |
Healthy: | No |
Age Range: | 18 - 90 |
Updated: | 12/13/2018 |
Start Date: | October 22, 2018 |
End Date: | June 2021 |
Contact: | Lars Oddsson, PhD |
Email: | loddsson@rxfunction.com |
Phone: | 612-358-2140 |
walk2Wellness: Long-term Use Effects of Walkasins® Wearable Sensory Prosthesis on Gait Function, Balance-Confidence, and Social Participation
The purpose of this study is to investigate the long-term effects of walkasins® use on
clinical and subject-reported outcomes of balance and gait function, quality of life,
physical activity/participation, pain, and medication use in persons with peripheral
neuropathy who experience balance problems.
clinical and subject-reported outcomes of balance and gait function, quality of life,
physical activity/participation, pain, and medication use in persons with peripheral
neuropathy who experience balance problems.
The main objective of the current study is to show a long-term (10 weeks) sustained
improvement in FGA score >4 following walkasins use as compared to initial baseline
assessment and to examine a potential relationship between initial baseline assessment data
and long-term outcome. The finding of a short-term FGA change >4 during walkasins® use
justifies a pre-post study design to investigate the long-term effects of walkasins use.
The investigators also intend to extend their observations of the short-term effects of
walkasins by replicating the randomized cross-over design of a previous short-term study.
(The replication will occur during the baseline visit.) This study will help to further
refine the prescription criteria for walkasins and determine whether the presence of a
short-term response is indicative of long-term improvements or not.
improvement in FGA score >4 following walkasins use as compared to initial baseline
assessment and to examine a potential relationship between initial baseline assessment data
and long-term outcome. The finding of a short-term FGA change >4 during walkasins® use
justifies a pre-post study design to investigate the long-term effects of walkasins use.
The investigators also intend to extend their observations of the short-term effects of
walkasins by replicating the randomized cross-over design of a previous short-term study.
(The replication will occur during the baseline visit.) This study will help to further
refine the prescription criteria for walkasins and determine whether the presence of a
short-term response is indicative of long-term improvements or not.
Inclusion Criteria:
- Age: 18-90 years, male or female
- Formal diagnosis of sensory peripheral neuropathy prior to participating in the study
- Self-reported balance problems
- Ability for transfers or ambulation on level surfaces at fixed cadence as assessed by
the physical therapist during the FGA
- FGA <23, the cut-off score for high fall-risk
- Ability to understand and provide informed consent
- Foot size that allows the walkasins® to function appropriately (women's size 5 through
men's size 12)
- Must be able to complete all functional outcome measures without the use of an
assistive device
Exclusion Criteria:
- Inability to perceive vibration from walkasins® leg unit
- Use of ankle-foot orthosis for ambulation that prevents donning of walkasins®
- Open wounds on the foot or calf as determined by clinician assessing risk
- Musculoskeletal or other neurological conditions that prohibit use of walkasins® as
determined by clinician
- Weighs more than 300 pounds
- Plans to begin balance physical therapy (PT) during the clinical trial
(Ongoing/current or previous balance PT is not an exclusionary criterion.)
We found this trial at
3
sites
Minneapolis, Minnesota 55417
Principal Investigator: Sara Koehler-McNicholas, PhD
Phone: 612-467-4705
Click here to add this to my saved trials
1200 Moursund Street
Houston, Texas 77030
Houston, Texas 77030
(713) 798-4951
Principal Investigator: Helen Cohen, EdD
Phone: 713-798-5233
Baylor College of Medicine Baylor College of Medicine in Houston, the only private medical school...
Click here to add this to my saved trials
Saint Paul, Minnesota 55114
Principal Investigator: Teresa Bisson, DPT
Phone: 612-273-6510
Click here to add this to my saved trials